ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 83 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $154,000 | -53.0% | 11,043 | -41.9% | 0.18% | -64.9% |
| Q1 2022 | $328,000 | -24.8% | 19,011 | -36.6% | 0.52% | -7.7% |
| Q4 2021 | $436,000 | -23.1% | 30,000 | -4.8% | 0.56% | -26.6% |
| Q3 2021 | $567,000 | -5.0% | 31,500 | -7.4% | 0.76% | -6.9% |
| Q2 2021 | $597,000 | +136.9% | 34,018 | +240.2% | 0.82% | +188.1% |
| Q1 2021 | $252,000 | -16.8% | 10,000 | -78.6% | 0.28% | -44.3% |
| Q4 2020 | $303,000 | -55.9% | 46,800 | -82.5% | 0.51% | -65.7% |
| Q3 2020 | $687,000 | -10.5% | 267,466 | -43.6% | 1.49% | -28.4% |
| Q2 2020 | $768,000 | +47.4% | 473,915 | -5.4% | 2.08% | +14.6% |
| Q1 2020 | $521,000 | -37.5% | 501,000 | +13.6% | 1.82% | -34.4% |
| Q4 2019 | $833,000 | +259.1% | 441,000 | +105.5% | 2.78% | +314.9% |
| Q3 2019 | $232,000 | -44.1% | 214,593 | +13.2% | 0.67% | +108.4% |
| Q2 2019 | $415,000 | -53.5% | 189,530 | +27.2% | 0.32% | -29.3% |
| Q1 2019 | $893,000 | +22.7% | 149,004 | +51.3% | 0.45% | -2.2% |
| Q4 2018 | $728,000 | +19.3% | 98,500 | +134.5% | 0.46% | +67.5% |
| Q3 2018 | $610,000 | -15.2% | 42,000 | +16.7% | 0.28% | +1.1% |
| Q2 2018 | $719,000 | -26.7% | 36,000 | -35.7% | 0.27% | -25.3% |
| Q1 2018 | $981,000 | – | 56,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |